JOTEC GmbH
20
1
11
5
Key Highlights
Risk & Performance
Pipeline Risk Assessment
Pipeline Risk Assessment
Based on historical performance
High Risk
Score: 60/100
15.0%
3 terminated/withdrawn out of 20 trials
62.5%
-24.0% vs industry average
0%
0 trials in Phase 3/4
0%
0 of 5 completed trials have results
Key Signals
Enrollment Performance
Analytics
Activity Timeline
Global Presence
Clinical Trials (20)
Data Collection of the TUVA BX and iCover Stent Grafts Implanted During Branched Endovascular Aortic Repair (BEVAR)
Role: lead
A Study in Patients With Thoracoabdominal Aortic Aneurysm Treated With the E-nside TAAA Multibranch Stent Graft System
Role: lead
Prospective Multicenter Study for the Endovascular Treatment of Iliac Aneurysm With the Branched E-liac Stent Graft
Role: lead
A PMCF Study in Patients With Thoracoabdominal Aortic Aneurysms Treated With E-nside TAAA Multibranch Stent Graft System (INNER-B-APAC)
Role: lead
Registry in Patients With Thoracoabdominal Aneurysms
Role: lead
Post-market Registry of the AMDS for the Treatment of Acute DeBakey Type I Dissection
Role: lead
Registry in Patients With Aorto-iliac or Iliac Aneurysms
Role: lead
EASYII - E-tegra Stent Graft System - Imaging Cohort
Role: lead
French Registry Conducted on E-vita OPEN NEO
Role: lead
Post Market Clinical Follow-Up Study in Patients Treated With the On-X Ascending Aortic Prosthesis (AAP)
Role: lead
A Study in Patients with a Descending TAA or PAU Treated with the E-nya Thoracic Stent Graft System
Role: lead
A PMCF Study in Patients With Infrarenal Aortic Aneurysm Treated With the E-tegra Stent Graft System
Role: lead
A Study in Patients With Complicated Type B Aortic Dissection Treated With the E-nya Thoracic Stent Graft
Role: lead
PMCF Study in Patients With Acute or Chronic Aortic Dissection or Aortic Aneurysm Treated With E-vita OPEN NEO
Role: lead
A PMCF Study in Patients With Acute or Chronic Aortic Dissection or Aortic Aneurysm Treated With E-vita OPEN NEO
Role: lead
Prospective/Retrospective Registry of the E-vita OPEN PLUS Stent Graft System in France
Role: lead
E-tegra Stent Graft System in the Treatment of Infra-renal Abdominal Aortic Aneurysms
Role: lead
A Post-Market Clinical Follow-up Study in Patients Treated With Vascular Grafts
Role: lead
Post-market Registry in Patients With Iliac Aneurysm Undergoing Endovascular Stenting With the E-liac Stent Graft System
Role: lead
A Study in SurvIvors of Type B Aortic Dissection Undergoing Stenting
Role: lead
All 20 trials loaded